In a research note released Wednesday, William Blair analyst Tim Lugo reiterated coverage on Zogenix, Inc. (ZGNX) with a Buy rating, which represents a potential upside of 119% from where the …
William Blair today maintained an Outperform rating on BioDelivery Sciences (BDSI) with $23.00 price target, which is derived through a net present value analysis …
